Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma
Clinical trial NCT07677813 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07677813
- Sponsor
- Ou Bai, MD/PHD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2029-12-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.